Trial Profile
A Phase II study of intermittent letrozole plus transdermal estradiol gel 3 month-therapy as adjuvant endocrine treatment for postmenopausal women with hormone-receptor positive early stage breast cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2014
Price :
$35
*
At a glance
- Drugs Estradiol (Primary) ; Letrozole
- Indications Breast cancer
- Focus Therapeutic Use
- 01 Jul 2014 New trial record